SCHEMBL7659745

SCHEMBL7659745

CN(Cc1csc(C(=O)Nc2c(O)cc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c1Cl)CC(O)CO

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F2 P00734 19/20 0.83
F10 P00742 17/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6593086 0.91 F2 (1.00) F2F10
SCHEMBL6588983 0.89 F2 (0.88) F2F10
SCHEMBL6591245 0.89 F2 (0.82) F2F10
SCHEMBL6591392 0.87 F2 (0.75) F2F10
SCHEMBL27475919 0.87 F2 (0.69) F2F10
SCHEMBL6592224 0.86 F2 (0.74) F2F10
SCHEMBL6590864 0.85 F2 (0.82) F2F10
SCHEMBL6596457 0.83 F2 (0.72) F2F10
SCHEMBL6591633 0.83 F2 (1.00) F2F10
SCHEMBL6596333 0.83 F2 (0.73) F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed